» Articles » PMID: 28686708

Drosophila Lines with Mutant and Wild Type Human TDP-43 Replacing the Endogenous Gene Reveals Phosphorylation and Ubiquitination in Mutant Lines in the Absence of Viability or Lifespan Defects

Overview
Journal PLoS One
Date 2017 Jul 8
PMID 28686708
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Mutations in TDP-43 are associated with proteinaceous inclusions in neurons and are believed to be causative in neurodegenerative diseases such as frontotemporal dementia or amyotrophic lateral sclerosis. Here we describe a Drosophila system where we have engineered the genome to replace the endogenous TDP-43 orthologue with wild type or mutant human TDP-43(hTDP-43). In contrast to other models, these flies express both mutant and wild type hTDP-43 at similar levels to those of the endogenous gene and importantly, no age-related TDP-43 accumulation observed among all the transgenic fly lines. Immunoprecipitation of TDP-43 showed that flies with hTDP-43 mutations had increased levels of ubiquitination and phosphorylation of the hTDP-43 protein. Furthermore, histologically, flies expressing hTDP-43 M337V showed global, robust neuronal staining for phospho-TDP. All three lines: wild type hTDP-43, -G294A and -M337V were homozygous viable, with no defects in development, life span or behaviors observed. The primary behavioral defect was that flies expressing either hTDP-43 G294A or M337V showed a faster decline with age in negative geotaxis. Together, these observations implied that neurons could handle these TDP-43 mutations by phosphorylation- and ubiquitin-dependent proteasome systems, even in a background without the wild type TDP-43. Our findings suggest that these two specific TDP-43 mutations are not inherently toxic, but may require additional environmental or genetic factors to affect longevity or survival.

Citing Articles

Humanization for neurological disease modeling: A roadmap to increase the potential of Drosophila model systems.

Katanaev V Animal Model Exp Med. 2023; 6(3):230-236.

PMID: 37323110 PMC: 10272901. DOI: 10.1002/ame2.12322.


Codon-optimized TDP-43 mediates neurodegeneration in a model of ALS/FTLD.

Yusuff T, Chang Y, Sang T, Jackson G, Chatterjee S Front Genet. 2023; 14:881638.

PMID: 36968586 PMC: 10034021. DOI: 10.3389/fgene.2023.881638.


Endogenous retroviruses and TDP-43 proteinopathy form a sustaining feedback driving intercellular spread of Drosophila neurodegeneration.

Chang Y, Dubnau J Nat Commun. 2023; 14(1):966.

PMID: 36810738 PMC: 9944888. DOI: 10.1038/s41467-023-36649-z.


The Role of TDP-43 in Neurodegenerative Disease.

Liao Y, Ma J, Dou J Mol Neurobiol. 2022; 59(7):4223-4241.

PMID: 35499795 DOI: 10.1007/s12035-022-02847-x.


Nearly 30 Years of Animal Models to Study Amyotrophic Lateral Sclerosis: A Historical Overview and Future Perspectives.

Bonifacino T, Zerbo R, Balbi M, Torazza C, Frumento G, Fedele E Int J Mol Sci. 2021; 22(22).

PMID: 34830115 PMC: 8619465. DOI: 10.3390/ijms222212236.


References
1.
Cragnaz L, Klima R, De Conti L, Romano G, Feiguin F, Buratti E . An age-related reduction of brain TBPH/TDP-43 levels precedes the onset of locomotion defects in a Drosophila ALS model. Neuroscience. 2015; 311:415-21. DOI: 10.1016/j.neuroscience.2015.10.037. View

2.
Tsai K, Yang C, Fang Y, Cho K, Chien W, Wang W . Elevated expression of TDP-43 in the forebrain of mice is sufficient to cause neurological and pathological phenotypes mimicking FTLD-U. J Exp Med. 2010; 207(8):1661-73. PMC: 2916125. DOI: 10.1084/jem.20092164. View

3.
Huang C, Tong J, Bi F, Zhou H, Xia X . Mutant TDP-43 in motor neurons promotes the onset and progression of ALS in rats. J Clin Invest. 2011; 122(1):107-18. PMC: 3248298. DOI: 10.1172/JCI59130. View

4.
Cheng C, Lin M, Shen C . Rapamycin alleviates pathogenesis of a new Drosophila model of ALS-TDP. J Neurogenet. 2015; 29(2-3):59-68. DOI: 10.3109/01677063.2015.1077832. View

5.
Liachko N, Guthrie C, Kraemer B . Phosphorylation promotes neurotoxicity in a Caenorhabditis elegans model of TDP-43 proteinopathy. J Neurosci. 2010; 30(48):16208-19. PMC: 3075589. DOI: 10.1523/JNEUROSCI.2911-10.2010. View